E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/29/2021 in the Prospect News Private Placement Daily.

Bio-Rad Laboratories loans €400 million to Sartorius-Herbst

Chicago, Nov. 29 – Bio-Rad Laboratories Inc. has loaned Sartorius-Herbst Beteiligungen II GmbH €400 million, according to an 8-K filed with the Securities and Exchange Commission.

The loan has a 1% interest rate and matures on Jan. 31, 2029.

Proceeds will be used to partially finance the acquisition of interests under the Sartorius Trust from another beneficiary of the trust.

The loan is collateralized by the pledge of trust interests under the trust.

Bio-Rad is a Hercules, Calif.-based manufacturer and supplier of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.